Home > Clinical Trials

Saved trials

RECRUITING
NCT05034887
Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients with HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma
64 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Gastric Adenocarcinoma


Gastroesophageal Junction Adenocarcinoma
COMPLETED
NCT04744831
Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer
122 Enrollment(s)
63 Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Colorectal Cancer
ACTIVE_NOT_RECRUITING
NCT06372483
Single Dose Trial of VMX-C001 in Healthy Subjects with and Without FXa Direct Oral Anticoagulant
40 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Coagulation Disorder
RECRUITING
NCT05965479
Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
25 Enrollment(s)
14 Study location(s)
INTERVENTIONAL (PHASE2)
Gastrooesophageal Cancer
COMPLETED
NCT03901352
Study of Mirogabalin for Central Neuropathic Pain
300 Enrollment(s)
118 Study location(s)
INTERVENTIONAL (PHASE3)
Central Neuropathic Pain
COMPLETED
NCT02612649
Special Drug Use Surveillance of Irribow in Female Patients
793 Enrollment(s)
34 Study location(s)
OBSERVATIONAL (None)
Diarrhea-predominant Irritable Bowel Syndrome
NOT_YET_RECRUITING
NCT06585969
A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer
504 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Metastatic Breast Cancer


ER-positive Breast Cancer


Luminal B


Her2 Enriched


Basal Like
연구종결
KCT0004754
자가인식 앱 피드백 시스템을 통한 edoxaban 약물 순응도 향상 연구: 무작위대조군연구
500 Enrollment(s)
1 Study location(s)
중재연구 (해당사항없음)